Solidarity Wealth’s Edwards Lifesciences EW Stock Holding History

Solidarity Wealth’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,673	Closed	-$1.03M	–	90
2024 Q3	$1.03M	Buy	+15,673	New	+$1.14M	0.28%	48

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Solidarity Wealth's EW Position: Q4 2024 in Review

Solidarity Wealth sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 15,673 shares — an estimated $1.03M sold.

Solidarity Wealth first reported a position in EW in Q3 2024 and held it in 1 quarter. The position peaked at $1.03M in Q3 2024. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2024.

Solidarity Wealth reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
Solidarity Wealth sold 15,673 Edwards Lifesciences shares in Q4 2024, an estimated $1.03M.
Solidarity Wealth first reported a position in Edwards Lifesciences in Q3 2024 and held it in 1 quarter.
Solidarity Wealth's Edwards Lifesciences position peaked at $1.03M in Q3 2024.
1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Solidarity Wealth's 13F filing for Q4 2024, filed 16 Jan 2025.